The role of psychotropic drugs in the insidious deconstruction of the Kraepelinian dichotomy
Language English Country Croatia Media print
Document type Journal Article
PubMed
18000488
Knihovny.cz E-resources
- MeSH
- Antipsychotic Agents therapeutic use MeSH
- Diagnostic and Statistical Manual of Mental Disorders MeSH
- Diagnosis, Differential MeSH
- Long-Term Care MeSH
- Humans MeSH
- Periodicity * MeSH
- Mood Disorders classification diagnosis drug therapy MeSH
- Prognosis MeSH
- Psychotic Disorders classification diagnosis drug therapy MeSH
- Psychotropic Drugs therapeutic use MeSH
- Retrospective Studies MeSH
- Schizophrenic Psychology * MeSH
- Schizophrenia classification diagnosis drug therapy MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Antipsychotic Agents MeSH
- Psychotropic Drugs MeSH
62 patients suffering from mood disorders or schizophrenia diagnosed retrospectively according to DSM-4 as 295.xx or 296.xx were followed up by the author personally for 20 years. The DSM-IV diagnosis of schizophrenia (295.xx) was changed to a diagnosis of a mood disorder in 13 patients (26%). If schizoaffective disorder is classified as a mood disorder to form a group of periodic disorders, 41% of patients diagnosed as "pure" schizophrenia (295.xx without 295.70) at the start of the observation period were re-diagnosed as periodic disorder over 20 years. This "retrogression" of schizophrenia is seen as a result of the treatment with psychotropic drugs. The Kraepelian dichotomy is based on the relationship between the symptomatic pattern (syndrome) and the course of the illness. This relationship is disrupted by long-term treatment with psychotropic drugs.